Search research articles
Contact Us
Filters
Showing results (41-50 of 57) with videos related to
Page
of 6
Sort By:
Circulation
|
March 9, 2005
Cytokine preconditioning promotes codifferentiation of human fetal liver CD133+ stem cells into angiomyogenic tissue
Sergey V Shmelkov, Sarah Meeus, Nelson Moussazadeh, et al.
Journal of the American College of Cardiology
|
July 7, 2022
Myosin Inhibition in Patients With Obstructive Hypertrophic Cardiomyopathy Referred for Septal Reduction Therapy
Milind Y Desai, Anjali Owens, Jeffrey B Geske, et al.
Journal of the American College of Cardiology
|
April 8, 2026
Efficacy of Tonlamarsen in Patients With Uncontrolled Hypertension: The KARDINAL Phase 2 Randomized Clinical Trial
Luke J Laffin, Qiuqing Wang, Ashish Sarraju, et al.
JACC. Advances
|
December 11, 2023
Patient-Level Artificial Intelligence-Enhanced Electrocardiography in Hypertrophic Cardiomyopathy: Longitudinal Treatment and Clinical Biomarker Correlations
Konstantinos C Siontis, Sean Abreau, Zachi I Attia, et al.
European Heart Journal
|
May 24, 2019
Effects of alirocumab on types of myocardial infarction: insights from the ODYSSEY OUTCOMES trial
Harvey D White, Ph Gabriel Steg, Michael Szarek, et al.
Journal of the American College of Cardiology
|
March 23, 2019
Alirocumab in Patients With Polyvascular Disease and Recent Acute Coronary Syndrome: ODYSSEY OUTCOMES Trial
J Wouter Jukema, Michael Szarek, Laurien E Zijlstra, et al.
Cardiovascular Drugs and Therapy
|
July 24, 2017
Navigating the Future of Cardiovascular Drug Development-Leveraging Novel Approaches to Drive Innovation and Drug Discovery: Summary of Findings from the Novel Cardiovascular Therapeutics Conference
Thomas J Povsic, Rob Scott, Kenneth W Mahaffey, et al.
Journal of the American College of Cardiology
|
August 31, 2019
Effects of Alirocumab on Cardiovascular Events After Coronary Bypass Surgery
Shaun G Goodman, Philip E Aylward, Michael Szarek, et al.
The New England Journal of Medicine
|
November 8, 2018
Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome
Gregory G Schwartz, P Gabriel Steg, Michael Szarek, et al.
Circulation
|
May 24, 2019
Effect of Alirocumab on Mortality After Acute Coronary Syndromes
Philippe Gabriel Steg, Michael Szarek, Deepak L Bhatt, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 57) with videos related to
Sort By:
Page
of 6
Circulation
|
March 9, 2005
Cytokine preconditioning promotes codifferentiation of human fetal liver CD133+ stem cells into angiomyogenic tissue
Sergey V Shmelkov, Sarah Meeus, Nelson Moussazadeh, et al.
Journal of the American College of Cardiology
|
July 7, 2022
Myosin Inhibition in Patients With Obstructive Hypertrophic Cardiomyopathy Referred for Septal Reduction Therapy
Milind Y Desai, Anjali Owens, Jeffrey B Geske, et al.
Journal of the American College of Cardiology
|
April 8, 2026
Efficacy of Tonlamarsen in Patients With Uncontrolled Hypertension: The KARDINAL Phase 2 Randomized Clinical Trial
Luke J Laffin, Qiuqing Wang, Ashish Sarraju, et al.
JACC. Advances
|
December 11, 2023
Patient-Level Artificial Intelligence-Enhanced Electrocardiography in Hypertrophic Cardiomyopathy: Longitudinal Treatment and Clinical Biomarker Correlations
Konstantinos C Siontis, Sean Abreau, Zachi I Attia, et al.
European Heart Journal
|
May 24, 2019
Effects of alirocumab on types of myocardial infarction: insights from the ODYSSEY OUTCOMES trial
Harvey D White, Ph Gabriel Steg, Michael Szarek, et al.
Journal of the American College of Cardiology
|
March 23, 2019
Alirocumab in Patients With Polyvascular Disease and Recent Acute Coronary Syndrome: ODYSSEY OUTCOMES Trial
J Wouter Jukema, Michael Szarek, Laurien E Zijlstra, et al.
Cardiovascular Drugs and Therapy
|
July 24, 2017
Navigating the Future of Cardiovascular Drug Development-Leveraging Novel Approaches to Drive Innovation and Drug Discovery: Summary of Findings from the Novel Cardiovascular Therapeutics Conference
Thomas J Povsic, Rob Scott, Kenneth W Mahaffey, et al.
Journal of the American College of Cardiology
|
August 31, 2019
Effects of Alirocumab on Cardiovascular Events After Coronary Bypass Surgery
Shaun G Goodman, Philip E Aylward, Michael Szarek, et al.
The New England Journal of Medicine
|
November 8, 2018
Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome
Gregory G Schwartz, P Gabriel Steg, Michael Szarek, et al.
Circulation
|
May 24, 2019
Effect of Alirocumab on Mortality After Acute Coronary Syndromes
Philippe Gabriel Steg, Michael Szarek, Deepak L Bhatt, et al.
Page
of 6